id	sid	tid	token	lemma	pos
ijpds-3082	1	1	padmakar	padmakar	ADJ
ijpds-3082	1	2	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	1	3	associated	associate	VERB
ijpds-3082	1	4	with	with	ADP
ijpds-3082	1	5	infective	infective	ADJ
ijpds-3082	1	6	mass	mass	NOUN
ijpds-3082	1	7	tumor	tumor	NOUN
ijpds-3082	1	8	vol	vol	NOUN
ijpds-3082	1	9	1	1	NUM
ijpds-3082	1	10	|	|	NOUN
ijpds-3082	1	11	issue	issue	NOUN
ijpds-3082	1	12	2	2	NUM
ijpds-3082	1	13	|	|	ADV
ijpds-3082	1	14	jul	jul	PROPN
ijpds-3082	1	15	–	–	PUNCT
ijpds-3082	1	16	sep	sep	PROPN
ijpds-3082	1	17	2022	2022	NUM
ijpds-3082	1	18	indian	indian	PROPN
ijpds-3082	1	19	j	j	PROPN
ijpds-3082	1	20	pharm	pharm	PROPN
ijpds-3082	1	21	drug	drug	PROPN
ijpds-3082	1	22	studies	study	NOUN
ijpds-3082	1	23	|	|	ADV
ijpds-3082	1	24	69	69	NUM
ijpds-3082	1	25	case	case	NOUN
ijpds-3082	1	26	report	report	VERB
ijpds-3082	1	27	a	a	DET
ijpds-3082	1	28	case	case	NOUN
ijpds-3082	1	29	report	report	NOUN
ijpds-3082	1	30	on	on	ADP
ijpds-3082	1	31	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	1	32	associated	associate	VERB
ijpds-3082	1	33	with	with	ADP
ijpds-3082	1	34	infective	infective	ADJ
ijpds-3082	1	35	mass	mass	NOUN
ijpds-3082	1	36	tumor	tumor	NOUN
ijpds-3082	1	37	somanaboina	somanaboina	VERB
ijpds-3082	1	38	padmakar	padmakar	NOUN
ijpds-3082	1	39	from	from	ADP
ijpds-3082	1	40	,	,	PUNCT
ijpds-3082	1	41	research	research	NOUN
ijpds-3082	1	42	scholar	scholar	NOUN
ijpds-3082	1	43	,	,	PUNCT
ijpds-3082	1	44	department	department	NOUN
ijpds-3082	1	45	of	of	ADP
ijpds-3082	1	46	pharmacology	pharmacology	NOUN
ijpds-3082	1	47	,	,	PUNCT
ijpds-3082	1	48	lovely	lovely	ADJ
ijpds-3082	1	49	professional	professional	ADJ
ijpds-3082	1	50	university	university	NOUN
ijpds-3082	1	51	.	.	PUNCT
ijpds-3082	2	1	correspondence	correspondence	NOUN
ijpds-3082	2	2	to	to	ADP
ijpds-3082	2	3	:	:	PUNCT
ijpds-3082	2	4	research	research	NOUN
ijpds-3082	2	5	scholar	scholar	NOUN
ijpds-3082	2	6	,	,	PUNCT
ijpds-3082	2	7	department	department	NOUN
ijpds-3082	2	8	of	of	ADP
ijpds-3082	2	9	pharmacology	pharmacology	NOUN
ijpds-3082	2	10	,	,	PUNCT
ijpds-3082	2	11	lovely	lovely	ADJ
ijpds-3082	2	12	professional	professional	ADJ
ijpds-3082	2	13	university	university	NOUN
ijpds-3082	2	14	,	,	PUNCT
ijpds-3082	2	15	phagwara	phagwara	ADJ
ijpds-3082	2	16	–	–	PUNCT
ijpds-3082	2	17	144001	144001	NUM
ijpds-3082	2	18	,	,	PUNCT
ijpds-3082	2	19	punjab	punjab	PROPN
ijpds-3082	2	20	,	,	PUNCT
ijpds-3082	2	21	india	india	PROPN
ijpds-3082	2	22	.	.	PUNCT
ijpds-3082	3	1	email	email	NOUN
ijpds-3082	3	2	:	:	PUNCT
ijpds-3082	3	3	spadmakar717@gmail.com	spadmakar717@gmail.com	X
ijpds-3082	4	1	abstract	abstract	ADJ
ijpds-3082	4	2	a	a	DET
ijpds-3082	4	3	rare	rare	ADJ
ijpds-3082	4	4	genetic	genetic	ADJ
ijpds-3082	4	5	disorder	disorder	NOUN
ijpds-3082	4	6	with	with	ADP
ijpds-3082	4	7	many	many	ADJ
ijpds-3082	4	8	non	non	ADJ
ijpds-3082	4	9	-	-	ADJ
ijpds-3082	4	10	cancerous	cancerous	ADJ
ijpds-3082	4	11	(	(	PUNCT
ijpds-3082	4	12	benign	benign	ADJ
ijpds-3082	4	13	)	)	PUNCT
ijpds-3082	4	14	tumors	tumor	NOUN
ijpds-3082	4	15	of	of	ADP
ijpds-3082	4	16	the	the	DET
ijpds-3082	4	17	skin	skin	NOUN
ijpds-3082	4	18	(	(	PUNCT
ijpds-3082	4	19	neurofibrom	neurofibrom	ADJ
ijpds-3082	4	20	as	as	ADP
ijpds-3082	4	21	)	)	PUNCT
ijpds-3082	4	22	and	and	CCONJ
ijpds-3082	4	23	nerves	nerve	NOUN
ijpds-3082	4	24	is	be	AUX
ijpds-3082	4	25	known	know	VERB
ijpds-3082	4	26	as	as	ADP
ijpds-3082	4	27	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	4	28	.	.	PUNCT
ijpds-3082	5	1	this	this	DET
ijpds-3082	5	2	disorder	disorder	NOUN
ijpds-3082	5	3	includes	include	VERB
ijpds-3082	5	4	type	type	NOUN
ijpds-3082	5	5	1	1	NUM
ijpds-3082	5	6	-	-	PUNCT
ijpds-3082	5	7	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	5	8	1	1	NUM
ijpds-3082	5	9	(	(	PUNCT
ijpds-3082	5	10	nf1	nf1	NOUN
ijpds-3082	5	11	)	)	PUNCT
ijpds-3082	5	12	,	,	PUNCT
ijpds-3082	5	13	type	type	NOUN
ijpds-3082	5	14	2	2	NUM
ijpds-3082	5	15	-	-	PUNCT
ijpds-3082	5	16	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	5	17	2	2	NUM
ijpds-3082	5	18	(	(	PUNCT
ijpds-3082	5	19	nf2	nf2	ADJ
ijpds-3082	5	20	)	)	PUNCT
ijpds-3082	5	21	,	,	PUNCT
ijpds-3082	5	22	and	and	CCONJ
ijpds-3082	5	23	schwannomatosis	schwannomatosis	NOUN
ijpds-3082	5	24	as	as	ADP
ijpds-3082	5	25	complex	complex	ADJ
ijpds-3082	5	26	genetic	genetic	ADJ
ijpds-3082	5	27	abnormalities	abnormality	NOUN
ijpds-3082	5	28	that	that	PRON
ijpds-3082	5	29	may	may	AUX
ijpds-3082	5	30	affect	affect	VERB
ijpds-3082	5	31	many	many	ADJ
ijpds-3082	5	32	different	different	ADJ
ijpds-3082	5	33	organ	organ	NOUN
ijpds-3082	5	34	systems	system	NOUN
ijpds-3082	5	35	in	in	ADP
ijpds-3082	5	36	the	the	DET
ijpds-3082	5	37	body	body	NOUN
ijpds-3082	5	38	.	.	PUNCT
ijpds-3082	6	1	when	when	SCONJ
ijpds-3082	6	2	alterations	alteration	NOUN
ijpds-3082	6	3	in	in	ADP
ijpds-3082	6	4	the	the	DET
ijpds-3082	6	5	gene	gene	NOUN
ijpds-3082	6	6	nf1	nf1	NOUN
ijpds-3082	6	7	,	,	PUNCT
ijpds-3082	6	8	located	locate	VERB
ijpds-3082	6	9	in	in	ADP
ijpds-3082	6	10	the	the	DET
ijpds-3082	6	11	17th	17th	ADJ
ijpds-3082	6	12	chromosome	chromosome	NOUN
ijpds-3082	6	13	occur	occur	NOUN
ijpds-3082	6	14	,	,	PUNCT
ijpds-3082	6	15	it	it	PRON
ijpds-3082	6	16	causes	cause	VERB
ijpds-3082	6	17	nf1	nf1	NOUN
ijpds-3082	6	18	type	type	NOUN
ijpds-3082	6	19	disorder	disorder	NOUN
ijpds-3082	6	20	.	.	PUNCT
ijpds-3082	7	1	nf1	nf1	NOUN
ijpds-3082	7	2	gene	gene	NOUN
ijpds-3082	7	3	controls	control	VERB
ijpds-3082	7	4	the	the	DET
ijpds-3082	7	5	synthesis	synthesis	NOUN
ijpds-3082	7	6	of	of	ADP
ijpds-3082	7	7	a	a	DET
ijpds-3082	7	8	specific	specific	ADJ
ijpds-3082	7	9	protein	protein	NOUN
ijpds-3082	7	10	called	call	VERB
ijpds-3082	7	11	neurofibromin	neurofibromin	NOUN
ijpds-3082	7	12	that	that	DET
ijpds-3082	7	13	functions	function	NOUN
ijpds-3082	7	14	as	as	ADP
ijpds-3082	7	15	a	a	DET
ijpds-3082	7	16	tumor	tumor	NOUN
ijpds-3082	7	17	suppressor	suppressor	NOUN
ijpds-3082	7	18	.	.	PUNCT
ijpds-3082	8	1	the	the	DET
ijpds-3082	8	2	predisposition	predisposition	NOUN
ijpds-3082	8	3	to	to	PART
ijpds-3082	8	4	form	form	VERB
ijpds-3082	8	5	tumors	tumor	NOUN
ijpds-3082	8	6	,	,	PUNCT
ijpds-3082	8	7	often	often	ADV
ijpds-3082	8	8	on	on	ADP
ijpds-3082	8	9	the	the	DET
ijpds-3082	8	10	nerves	nerve	NOUN
ijpds-3082	8	11	,	,	PUNCT
ijpds-3082	8	12	spine	spine	NOUN
ijpds-3082	8	13	,	,	PUNCT
ijpds-3082	8	14	brain	brain	NOUN
ijpds-3082	8	15	,	,	PUNCT
ijpds-3082	8	16	and	and	CCONJ
ijpds-3082	8	17	skin	skin	NOUN
ijpds-3082	8	18	,	,	PUNCT
ijpds-3082	8	19	is	be	AUX
ijpds-3082	8	20	a	a	DET
ijpds-3082	8	21	common	common	ADJ
ijpds-3082	8	22	characteristic	characteristic	NOUN
ijpds-3082	8	23	of	of	ADP
ijpds-3082	8	24	these	these	DET
ijpds-3082	8	25	disorders	disorder	NOUN
ijpds-3082	8	26	.	.	PUNCT
ijpds-3082	9	1	but	but	CCONJ
ijpds-3082	9	2	the	the	DET
ijpds-3082	9	3	types	type	NOUN
ijpds-3082	9	4	and	and	CCONJ
ijpds-3082	9	5	severity	severity	NOUN
ijpds-3082	9	6	of	of	ADP
ijpds-3082	9	7	symptoms	symptom	NOUN
ijpds-3082	9	8	vary	vary	VERB
ijpds-3082	9	9	widely	widely	ADV
ijpds-3082	9	10	among	among	ADP
ijpds-3082	9	11	individuals	individual	NOUN
ijpds-3082	9	12	.	.	PUNCT
ijpds-3082	10	1	here	here	ADV
ijpds-3082	10	2	,	,	PUNCT
ijpds-3082	10	3	we	we	PRON
ijpds-3082	10	4	present	present	VERB
ijpds-3082	10	5	a	a	DET
ijpds-3082	10	6	case	case	NOUN
ijpds-3082	10	7	of	of	ADP
ijpds-3082	10	8	nf-1	nf-1	NUM
ijpds-3082	10	9	with	with	ADP
ijpds-3082	10	10	a	a	DET
ijpds-3082	10	11	severe	severe	ADJ
ijpds-3082	10	12	infective	infective	ADJ
ijpds-3082	10	13	tumor	tumor	NOUN
ijpds-3082	10	14	lesion	lesion	NOUN
ijpds-3082	10	15	on	on	ADP
ijpds-3082	10	16	the	the	DET
ijpds-3082	10	17	left	left	ADJ
ijpds-3082	10	18	hand	hand	NOUN
ijpds-3082	10	19	.	.	PUNCT
ijpds-3082	11	1	a	a	DET
ijpds-3082	11	2	56	56	NUM
ijpds-3082	11	3	-	-	PUNCT
ijpds-3082	11	4	year	year	NOUN
ijpds-3082	11	5	-	-	PUNCT
ijpds-3082	11	6	old	old	ADJ
ijpds-3082	11	7	male	male	NOUN
ijpds-3082	11	8	was	be	AUX
ijpds-3082	11	9	admitted	admit	VERB
ijpds-3082	11	10	to	to	ADP
ijpds-3082	11	11	the	the	DET
ijpds-3082	11	12	dermatology	dermatology	NOUN
ijpds-3082	11	13	department	department	NOUN
ijpds-3082	11	14	with	with	ADP
ijpds-3082	11	15	a	a	DET
ijpds-3082	11	16	chief	chief	ADJ
ijpds-3082	11	17	complaint	complaint	NOUN
ijpds-3082	11	18	of	of	ADP
ijpds-3082	11	19	a	a	DET
ijpds-3082	11	20	mass	mass	ADJ
ijpds-3082	11	21	lesion	lesion	NOUN
ijpds-3082	11	22	on	on	ADP
ijpds-3082	11	23	the	the	DET
ijpds-3082	11	24	hand	hand	NOUN
ijpds-3082	11	25	that	that	PRON
ijpds-3082	11	26	was	be	AUX
ijpds-3082	11	27	painful	painful	ADJ
ijpds-3082	11	28	,	,	PUNCT
ijpds-3082	11	29	severely	severely	ADV
ijpds-3082	11	30	itchily	itchily	ADV
ijpds-3082	11	31	,	,	PUNCT
ijpds-3082	11	32	and	and	CCONJ
ijpds-3082	11	33	progressively	progressively	ADV
ijpds-3082	11	34	increased	increase	VERB
ijpds-3082	11	35	in	in	ADP
ijpds-3082	11	36	size	size	NOUN
ijpds-3082	11	37	.	.	PUNCT
ijpds-3082	12	1	multiple	multiple	ADJ
ijpds-3082	12	2	neurofibromas	neurofibroma	NOUN
ijpds-3082	12	3	were	be	AUX
ijpds-3082	12	4	found	find	VERB
ijpds-3082	12	5	on	on	ADP
ijpds-3082	12	6	his	his	PRON
ijpds-3082	12	7	body	body	NOUN
ijpds-3082	12	8	that	that	PRON
ijpds-3082	12	9	are	be	AUX
ijpds-3082	12	10	soft	soft	ADJ
ijpds-3082	12	11	,	,	PUNCT
ijpds-3082	12	12	fleshy	fleshy	ADJ
ijpds-3082	12	13	tumors	tumor	NOUN
ijpds-3082	12	14	arising	arise	VERB
ijpds-3082	12	15	from	from	ADP
ijpds-3082	12	16	a	a	DET
ijpds-3082	12	17	peripheral	peripheral	ADJ
ijpds-3082	12	18	nerve	nerve	NOUN
ijpds-3082	12	19	sheath	sheath	NOUN
ijpds-3082	12	20	near	near	ADP
ijpds-3082	12	21	the	the	DET
ijpds-3082	12	22	surface	surface	NOUN
ijpds-3082	12	23	of	of	ADP
ijpds-3082	12	24	the	the	DET
ijpds-3082	12	25	skin	skin	NOUN
ijpds-3082	12	26	,	,	PUNCT
ijpds-3082	12	27	or	or	CCONJ
ijpds-3082	12	28	on	on	ADP
ijpds-3082	12	29	the	the	DET
ijpds-3082	12	30	skin	skin	NOUN
ijpds-3082	12	31	,	,	PUNCT
ijpds-3082	12	32	and	and	CCONJ
ijpds-3082	12	33	he	he	PRON
ijpds-3082	12	34	had	have	AUX
ijpds-3082	12	35	already	already	ADV
ijpds-3082	12	36	been	be	AUX
ijpds-3082	12	37	diagnosed	diagnose	VERB
ijpds-3082	12	38	in	in	ADP
ijpds-3082	12	39	his	his	PRON
ijpds-3082	12	40	childhood	childhood	NOUN
ijpds-3082	12	41	as	as	ADP
ijpds-3082	12	42	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	12	43	.	.	PUNCT
ijpds-3082	13	1	keywords	keyword	NOUN
ijpds-3082	13	2	:	:	PUNCT
ijpds-3082	13	3	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	13	4	type	type	NOUN
ijpds-3082	13	5	1	1	NUM
ijpds-3082	13	6	,	,	PUNCT
ijpds-3082	13	7	neurofibromas	neurofibroma	NOUN
ijpds-3082	13	8	,	,	PUNCT
ijpds-3082	13	9	schwannomatosis	schwannomatosis	NOUN
ijpds-3082	13	10	eurofibromatosis	eurofibromatosis	NOUN
ijpds-3082	13	11	type	type	NOUN
ijpds-3082	13	12	1	1	NUM
ijpds-3082	13	13	(	(	PUNCT
ijpds-3082	13	14	nf1	nf1	NOUN
ijpds-3082	13	15	)	)	PUNCT
ijpds-3082	13	16	is	be	AUX
ijpds-3082	13	17	the	the	DET
ijpds-3082	13	18	most	most	ADV
ijpds-3082	13	19	frequent	frequent	ADJ
ijpds-3082	13	20	single	single	ADJ
ijpds-3082	13	21	-	-	PUNCT
ijpds-3082	13	22	gene	gene	NOUN
ijpds-3082	13	23	disorder	disorder	NOUN
ijpds-3082	13	24	affecting	affect	VERB
ijpds-3082	13	25	the	the	DET
ijpds-3082	13	26	human	human	ADJ
ijpds-3082	13	27	nervous	nervous	ADJ
ijpds-3082	13	28	system	system	NOUN
ijpds-3082	13	29	,	,	PUNCT
ijpds-3082	13	30	an	an	DET
ijpds-3082	13	31	estimated	estimate	VERB
ijpds-3082	13	32	prevalence	prevalence	NOUN
ijpds-3082	13	33	of	of	ADP
ijpds-3082	13	34	2	2	NUM
ijpds-3082	13	35	to	to	PART
ijpds-3082	13	36	3	3	NUM
ijpds-3082	13	37	cases	case	NOUN
ijpds-3082	13	38	per	per	ADP
ijpds-3082	13	39	10,000	10,000	NUM
ijpds-3082	13	40	people	people	NOUN
ijpds-3082	13	41	.	.	PUNCT
ijpds-3082	14	1	he	he	PRON
ijpds-3082	14	2	inherited	inherit	VERB
ijpds-3082	14	3	this	this	DET
ijpds-3082	14	4	disorder	disorder	NOUN
ijpds-3082	14	5	autosomally	autosomally	ADV
ijpds-3082	14	6	dominant	dominant	ADJ
ijpds-3082	14	7	,	,	PUNCT
ijpds-3082	14	8	with	with	ADP
ijpds-3082	14	9	an	an	DET
ijpds-3082	14	10	equal	equal	ADJ
ijpds-3082	14	11	sex	sex	NOUN
ijpds-3082	14	12	incidence	incidence	NOUN
ijpds-3082	14	13	.	.	PUNCT
ijpds-3082	15	1	the	the	DET
ijpds-3082	15	2	neurocutaneous	neurocutaneous	ADJ
ijpds-3082	15	3	abnormalities	abnormality	NOUN
ijpds-3082	15	4	like	like	ADP
ijpds-3082	15	5	axillary	axillary	ADJ
ijpds-3082	15	6	freckling	freckling	NOUN
ijpds-3082	15	7	,	,	PUNCT
ijpds-3082	15	8	cafe	cafe	NOUN
ijpds-3082	15	9	-	-	PUNCT
ijpds-3082	15	10	au	au	ADP
ijpds-3082	15	11	-	-	PUNCT
ijpds-3082	15	12	lait	lait	ADJ
ijpds-3082	15	13	spots	spot	NOUN
ijpds-3082	15	14	,	,	PUNCT
ijpds-3082	15	15	iris	iris	NOUN
ijpds-3082	15	16	hamartomas	hamartoma	NOUN
ijpds-3082	15	17	(	(	PUNCT
ijpds-3082	15	18	lisch	lisch	ADJ
ijpds-3082	15	19	nodules	nodule	NOUN
ijpds-3082	15	20	)	)	PUNCT
ijpds-3082	15	21	,	,	PUNCT
ijpds-3082	15	22	and	and	CCONJ
ijpds-3082	15	23	cutaneous	cutaneous	ADJ
ijpds-3082	15	24	neurofibromas	neurofibroma	NOUN
ijpds-3082	15	25	were	be	AUX
ijpds-3082	15	26	diagnosed	diagnose	VERB
ijpds-3082	15	27	in	in	ADP
ijpds-3082	15	28	individuals	individual	NOUN
ijpds-3082	15	29	with	with	ADP
ijpds-3082	15	30	nf-1	nf-1	NUM
ijpds-3082	15	31	type	type	NOUN
ijpds-3082	15	32	disorder	disorder	NOUN
ijpds-3082	15	33	[	[	X
ijpds-3082	15	34	1	1	NUM
ijpds-3082	15	35	]	]	PUNCT
ijpds-3082	15	36	.	.	PUNCT
ijpds-3082	16	1	neurofibroma	neurofibroma	NOUN
ijpds-3082	16	2	consists	consist	VERB
ijpds-3082	16	3	of	of	ADP
ijpds-3082	16	4	a	a	DET
ijpds-3082	16	5	varied	varied	ADJ
ijpds-3082	16	6	mixture	mixture	NOUN
ijpds-3082	16	7	of	of	ADP
ijpds-3082	16	8	schwann	schwann	PROPN
ijpds-3082	16	9	's	's	PART
ijpds-3082	16	10	cells	cell	NOUN
ijpds-3082	16	11	,	,	PUNCT
ijpds-3082	16	12	perineurial	perineurial	ADJ
ijpds-3082	16	13	-	-	PUNCT
ijpds-3082	16	14	like	like	ADJ
ijpds-3082	16	15	cells	cell	NOUN
ijpds-3082	16	16	,	,	PUNCT
ijpds-3082	16	17	and	and	CCONJ
ijpds-3082	16	18	fibroblasts	fibroblast	NOUN
ijpds-3082	16	19	,	,	PUNCT
ijpds-3082	16	20	which	which	PRON
ijpds-3082	16	21	is	be	AUX
ijpds-3082	16	22	a	a	DET
ijpds-3082	16	23	benign	benign	ADJ
ijpds-3082	16	24	tumor	tumor	NOUN
ijpds-3082	16	25	deriving	derive	VERB
ijpds-3082	16	26	from	from	ADP
ijpds-3082	16	27	peripheral	peripheral	ADJ
ijpds-3082	16	28	nerve	nerve	NOUN
ijpds-3082	16	29	sheathing	sheathing	NOUN
ijpds-3082	16	30	[	[	X
ijpds-3082	16	31	2	2	NUM
ijpds-3082	16	32	]	]	PUNCT
ijpds-3082	16	33	.	.	PUNCT
ijpds-3082	17	1	nf1	nf1	NOUN
ijpds-3082	17	2	causes	cause	VERB
ijpds-3082	17	3	mutations	mutation	NOUN
ijpds-3082	17	4	in	in	ADP
ijpds-3082	17	5	the	the	DET
ijpds-3082	17	6	nf1	nf1	NOUN
ijpds-3082	17	7	gene	gene	NOUN
ijpds-3082	17	8	,	,	PUNCT
ijpds-3082	17	9	the	the	DET
ijpds-3082	17	10	neurofibromin	neurofibromin	NOUN
ijpds-3082	17	11	-	-	PUNCT
ijpds-3082	17	12	encoded	encode	VERB
ijpds-3082	17	13	60exon	60exon	NUM
ijpds-3082	17	14	tumor	tumor	NOUN
ijpds-3082	17	15	suppressor	suppressor	NOUN
ijpds-3082	17	16	locus	locus	NOUN
ijpds-3082	17	17	of	of	ADP
ijpds-3082	17	18	17q11.2	17q11.2	NUM
ijpds-3082	17	19	.	.	PUNCT
ijpds-3082	18	1	many	many	ADJ
ijpds-3082	18	2	malignancies	malignancy	NOUN
ijpds-3082	18	3	of	of	ADP
ijpds-3082	18	4	nf1	nf1	NOUN
ijpds-3082	18	5	were	be	AUX
ijpds-3082	18	6	observed	observe	VERB
ijpds-3082	18	7	for	for	ADP
ijpds-3082	18	8	heterozygotic	heterozygotic	ADJ
ijpds-3082	18	9	loss	loss	NOUN
ijpds-3082	18	10	(	(	PUNCT
ijpds-3082	18	11	loh	loh	PROPN
ijpds-3082	18	12	)	)	PUNCT
ijpds-3082	18	13	in	in	ADP
ijpds-3082	18	14	chromosome	chromosome	NOUN
ijpds-3082	18	15	17	17	NUM
ijpds-3082	18	16	(	(	PUNCT
ijpds-3082	18	17	including	include	VERB
ijpds-3082	18	18	locus	locus	ADJ
ijpds-3082	18	19	nf1	nf1	NOUN
ijpds-3082	18	20	)	)	PUNCT
ijpds-3082	19	1	[	[	X
ijpds-3082	19	2	3	3	NUM
ijpds-3082	19	3	]	]	PUNCT
ijpds-3082	19	4	.	.	PUNCT
ijpds-3082	20	1	nf1	nf1	NOUN
ijpds-3082	20	2	can	can	AUX
ijpds-3082	20	3	be	be	AUX
ijpds-3082	20	4	evaluated	evaluate	VERB
ijpds-3082	20	5	by	by	ADP
ijpds-3082	20	6	a	a	DET
ijpds-3082	20	7	clinical	clinical	ADJ
ijpds-3082	20	8	examination	examination	NOUN
ijpds-3082	20	9	and	and	CCONJ
ijpds-3082	20	10	by	by	ADP
ijpds-3082	20	11	a	a	DET
ijpds-3082	20	12	family	family	NOUN
ijpds-3082	20	13	history	history	NOUN
ijpds-3082	20	14	of	of	ADP
ijpds-3082	20	15	the	the	DET
ijpds-3082	20	16	patient	patient	NOUN
ijpds-3082	20	17	.	.	PUNCT
ijpds-3082	21	1	the	the	DET
ijpds-3082	21	2	diagnosis	diagnosis	NOUN
ijpds-3082	21	3	of	of	ADP
ijpds-3082	21	4	nf1	nf1	NOUN
ijpds-3082	21	5	is	be	AUX
ijpds-3082	21	6	based	base	VERB
ijpds-3082	21	7	on	on	ADP
ijpds-3082	21	8	the	the	DET
ijpds-3082	21	9	diagnostic	diagnostic	ADJ
ijpds-3082	21	10	criteria	criterion	NOUN
ijpds-3082	21	11	of	of	ADP
ijpds-3082	21	12	the	the	DET
ijpds-3082	21	13	national	national	PROPN
ijpds-3082	21	14	health	health	PROPN
ijpds-3082	21	15	institutes	institutes	PROPN
ijpds-3082	21	16	(	(	PUNCT
ijpds-3082	21	17	nih	nih	PROPN
ijpds-3082	21	18	)	)	PUNCT
ijpds-3082	21	19	.	.	PUNCT
ijpds-3082	22	1	these	these	DET
ijpds-3082	22	2	criteria	criterion	NOUN
ijpds-3082	22	3	typically	typically	ADV
ijpds-3082	22	4	appear	appear	VERB
ijpds-3082	22	5	in	in	ADP
ijpds-3082	22	6	the	the	DET
ijpds-3082	22	7	following	follow	VERB
ijpds-3082	22	8	predictable	predictable	ADJ
ijpds-3082	22	9	order	order	NOUN
ijpds-3082	22	10	:	:	PUNCT
ijpds-3082	22	11	café	café	NOUN
ijpds-3082	22	12	-	-	PUNCT
ijpds-3082	22	13	au	au	ADP
ijpds-3082	22	14	-	-	PUNCT
ijpds-3082	22	15	lait	lait	ADJ
ijpds-3082	22	16	macules	macule	NOUN
ijpds-3082	22	17	,	,	PUNCT
ijpds-3082	22	18	axillary	axillary	ADJ
ijpds-3082	22	19	freckling	freckling	ADJ
ijpds-3082	22	20	,	,	PUNCT
ijpds-3082	22	21	lisch	lisch	ADJ
ijpds-3082	22	22	nodules	nodule	NOUN
ijpds-3082	22	23	,	,	PUNCT
ijpds-3082	22	24	and	and	CCONJ
ijpds-3082	22	25	neurofibromas	neurofibroma	NOUN
ijpds-3082	22	26	[	[	X
ijpds-3082	22	27	4	4	NUM
ijpds-3082	22	28	]	]	PUNCT
ijpds-3082	22	29	.	.	PUNCT
ijpds-3082	23	1	the	the	DET
ijpds-3082	23	2	distribution	distribution	NOUN
ijpds-3082	23	3	of	of	ADP
ijpds-3082	23	4	the	the	DET
ijpds-3082	23	5	affected	affected	ADJ
ijpds-3082	23	6	nerve	nerve	NOUN
ijpds-3082	23	7	is	be	AUX
ijpds-3082	23	8	evident	evident	ADJ
ijpds-3082	23	9	for	for	ADP
ijpds-3082	23	10	cutaneous	cutaneous	ADJ
ijpds-3082	23	11	neurofibroma	neurofibroma	NOUN
ijpds-3082	23	12	in	in	ADP
ijpds-3082	23	13	the	the	DET
ijpds-3082	23	14	skin	skin	NOUN
ijpds-3082	23	15	palpating	palpating	NOUN
ijpds-3082	23	16	,	,	PUNCT
ijpds-3082	23	17	tenderness	tenderness	NOUN
ijpds-3082	23	18	to	to	PART
ijpds-3082	23	19	touch	touch	VERB
ijpds-3082	23	20	,	,	PUNCT
ijpds-3082	23	21	and	and	CCONJ
ijpds-3082	23	22	tingling	tingle	VERB
ijpds-3082	23	23	.	.	PUNCT
ijpds-3082	24	1	malignant	malignant	ADJ
ijpds-3082	24	2	changes	change	NOUN
ijpds-3082	24	3	occur	occur	VERB
ijpds-3082	24	4	rarely	rarely	ADV
ijpds-3082	24	5	,	,	PUNCT
ijpds-3082	24	6	and	and	CCONJ
ijpds-3082	24	7	if	if	SCONJ
ijpds-3082	24	8	removal	removal	NOUN
ijpds-3082	24	9	intended	intend	VERB
ijpds-3082	24	10	,	,	PUNCT
ijpds-3082	24	11	should	should	AUX
ijpds-3082	24	12	consult	consult	VERB
ijpds-3082	24	13	expert	expert	ADJ
ijpds-3082	24	14	assistance	assistance	NOUN
ijpds-3082	24	15	either	either	CCONJ
ijpds-3082	24	16	from	from	ADP
ijpds-3082	24	17	a	a	DET
ijpds-3082	24	18	soft	soft	ADJ
ijpds-3082	24	19	tissue	tissue	NOUN
ijpds-3082	24	20	tumor	tumor	NOUN
ijpds-3082	24	21	/	/	SYM
ijpds-3082	24	22	peripheral	peripheral	ADJ
ijpds-3082	24	23	nerve	nerve	NOUN
ijpds-3082	24	24	surgeon	surgeon	NOUN
ijpds-3082	24	25	,	,	PUNCT
ijpds-3082	24	26	and	and	CCONJ
ijpds-3082	24	27	the	the	DET
ijpds-3082	24	28	removal	removal	NOUN
ijpds-3082	24	29	results	result	VERB
ijpds-3082	24	30	occasionally	occasionally	ADV
ijpds-3082	24	31	in	in	ADP
ijpds-3082	24	32	a	a	DET
ijpds-3082	24	33	neurological	neurological	ADJ
ijpds-3082	24	34	deficit	deficit	NOUN
ijpds-3082	24	35	[	[	X
ijpds-3082	24	36	5	5	NUM
ijpds-3082	24	37	]	]	PUNCT
ijpds-3082	24	38	.	.	PUNCT
ijpds-3082	25	1	the	the	DET
ijpds-3082	25	2	present	present	ADJ
ijpds-3082	25	3	study	study	NOUN
ijpds-3082	25	4	describes	describe	VERB
ijpds-3082	25	5	a	a	DET
ijpds-3082	25	6	case	case	NOUN
ijpds-3082	25	7	of	of	ADP
ijpds-3082	25	8	an	an	DET
ijpds-3082	25	9	infective	infective	ADJ
ijpds-3082	25	10	mass	mass	NOUN
ijpds-3082	25	11	tumor	tumor	NOUN
ijpds-3082	25	12	over	over	ADP
ijpds-3082	25	13	the	the	DET
ijpds-3082	25	14	left	left	ADJ
ijpds-3082	25	15	hand	hand	NOUN
ijpds-3082	25	16	in	in	ADP
ijpds-3082	25	17	an	an	DET
ijpds-3082	25	18	nf1	nf1	NOUN
ijpds-3082	25	19	patient	patient	NOUN
ijpds-3082	25	20	.	.	PUNCT
ijpds-3082	26	1	case	case	NOUN
ijpds-3082	26	2	report	report	VERB
ijpds-3082	26	3	a	a	DET
ijpds-3082	26	4	56	56	NUM
ijpds-3082	26	5	-	-	PUNCT
ijpds-3082	26	6	year	year	NOUN
ijpds-3082	26	7	-	-	PUNCT
ijpds-3082	26	8	old	old	ADJ
ijpds-3082	26	9	male	male	NOUN
ijpds-3082	26	10	had	have	AUX
ijpds-3082	26	11	been	be	AUX
ijpds-3082	26	12	admitted	admit	VERB
ijpds-3082	26	13	to	to	ADP
ijpds-3082	26	14	the	the	DET
ijpds-3082	26	15	dermatology	dermatology	NOUN
ijpds-3082	26	16	department	department	NOUN
ijpds-3082	26	17	,	,	PUNCT
ijpds-3082	26	18	government	government	NOUN
ijpds-3082	26	19	general	general	ADJ
ijpds-3082	26	20	hospital	hospital	NOUN
ijpds-3082	26	21	,	,	PUNCT
ijpds-3082	26	22	kadapa	kadapa	PROPN
ijpds-3082	26	23	,	,	PUNCT
ijpds-3082	26	24	with	with	ADP
ijpds-3082	26	25	a	a	DET
ijpds-3082	26	26	chief	chief	ADJ
ijpds-3082	26	27	complaint	complaint	NOUN
ijpds-3082	26	28	of	of	ADP
ijpds-3082	26	29	mild	mild	ADJ
ijpds-3082	26	30	fever	fever	NOUN
ijpds-3082	26	31	,	,	PUNCT
ijpds-3082	26	32	swelling	swell	VERB
ijpds-3082	26	33	lesion	lesion	NOUN
ijpds-3082	26	34	on	on	ADP
ijpds-3082	26	35	the	the	DET
ijpds-3082	26	36	hand	hand	NOUN
ijpds-3082	26	37	which	which	PRON
ijpds-3082	26	38	is	be	AUX
ijpds-3082	26	39	progressively	progressively	ADV
ijpds-3082	26	40	increasing	increase	VERB
ijpds-3082	26	41	in	in	ADP
ijpds-3082	26	42	size	size	NOUN
ijpds-3082	26	43	,	,	PUNCT
ijpds-3082	26	44	painful	painful	ADJ
ijpds-3082	26	45	and	and	CCONJ
ijpds-3082	26	46	severe	severe	ADJ
ijpds-3082	26	47	itchy	itchy	ADJ
ijpds-3082	26	48	for	for	ADP
ijpds-3082	26	49	three	three	NUM
ijpds-3082	26	50	months	month	NOUN
ijpds-3082	26	51	.	.	PUNCT
ijpds-3082	27	1	the	the	DET
ijpds-3082	27	2	patient	patient	NOUN
ijpds-3082	27	3	had	have	VERB
ijpds-3082	27	4	a	a	DET
ijpds-3082	27	5	history	history	NOUN
ijpds-3082	27	6	of	of	ADP
ijpds-3082	27	7	multiple	multiple	ADJ
ijpds-3082	27	8	raised	raise	VERB
ijpds-3082	27	9	nonitchy	nonitchy	ADJ
ijpds-3082	27	10	neurofibromas	neurofibroma	NOUN
ijpds-3082	27	11	over	over	ADP
ijpds-3082	27	12	the	the	DET
ijpds-3082	27	13	hands	hand	NOUN
ijpds-3082	27	14	,	,	PUNCT
ijpds-3082	27	15	followed	follow	VERB
ijpds-3082	27	16	by	by	ADP
ijpds-3082	27	17	similar	similar	ADJ
ijpds-3082	27	18	lesions	lesion	NOUN
ijpds-3082	27	19	on	on	ADP
ijpds-3082	27	20	the	the	DET
ijpds-3082	27	21	face	face	NOUN
ijpds-3082	27	22	,	,	PUNCT
ijpds-3082	27	23	legs	leg	NOUN
ijpds-3082	27	24	,	,	PUNCT
ijpds-3082	27	25	and	and	CCONJ
ijpds-3082	27	26	body	body	NOUN
ijpds-3082	27	27	folds	fold	NOUN
ijpds-3082	27	28	at	at	ADP
ijpds-3082	27	29	two	two	NUM
ijpds-3082	27	30	years	year	NOUN
ijpds-3082	27	31	of	of	ADP
ijpds-3082	27	32	age	age	NOUN
ijpds-3082	27	33	.	.	PUNCT
ijpds-3082	28	1	there	there	PRON
ijpds-3082	28	2	was	be	VERB
ijpds-3082	28	3	no	no	DET
ijpds-3082	28	4	family	family	NOUN
ijpds-3082	28	5	history	history	NOUN
ijpds-3082	28	6	of	of	ADP
ijpds-3082	28	7	nf	nf	NOUN
ijpds-3082	28	8	.	.	PUNCT
ijpds-3082	29	1	there	there	PRON
ijpds-3082	29	2	were	be	VERB
ijpds-3082	29	3	no	no	DET
ijpds-3082	29	4	neurological	neurological	ADJ
ijpds-3082	29	5	abnormalities	abnormality	NOUN
ijpds-3082	29	6	,	,	PUNCT
ijpds-3082	29	7	skeletal	skeletal	ADJ
ijpds-3082	29	8	malformations	malformation	NOUN
ijpds-3082	29	9	noted	note	VERB
ijpds-3082	29	10	.	.	PUNCT
ijpds-3082	30	1	multiple	multiple	ADJ
ijpds-3082	30	2	cafe	cafe	NOUN
ijpds-3082	30	3	-	-	PUNCT
ijpds-3082	30	4	aulait	aulait	ADJ
ijpds-3082	30	5	spots	spot	NOUN
ijpds-3082	30	6	disseminated	disseminate	VERB
ijpds-3082	30	7	on	on	ADP
ijpds-3082	30	8	his	his	PRON
ijpds-3082	30	9	body	body	NOUN
ijpds-3082	30	10	,	,	PUNCT
ijpds-3082	30	11	several	several	ADJ
ijpds-3082	30	12	soft	soft	ADJ
ijpds-3082	30	13	,	,	PUNCT
ijpds-3082	30	14	fleshy	fleshy	ADJ
ijpds-3082	30	15	tumors	tumor	NOUN
ijpds-3082	30	16	arose	arise	VERB
ijpds-3082	30	17	from	from	ADP
ijpds-3082	30	18	a	a	DET
ijpds-3082	30	19	peripheral	peripheral	ADJ
ijpds-3082	30	20	nerve	nerve	NOUN
ijpds-3082	30	21	sheath	sheath	NOUN
ijpds-3082	30	22	near	near	ADP
ijpds-3082	30	23	the	the	DET
ijpds-3082	30	24	skin	skin	NOUN
ijpds-3082	30	25	surface	surface	NOUN
ijpds-3082	30	26	diagnosed	diagnose	VERB
ijpds-3082	30	27	in	in	ADP
ijpds-3082	30	28	clinical	clinical	ADJ
ijpds-3082	30	29	examination	examination	NOUN
ijpds-3082	30	30	.	.	PUNCT
ijpds-3082	31	1	he	he	PRON
ijpds-3082	31	2	was	be	AUX
ijpds-3082	31	3	diagnosed	diagnose	VERB
ijpds-3082	31	4	in	in	ADP
ijpds-3082	31	5	his	his	PRON
ijpds-3082	31	6	childhood	childhood	NOUN
ijpds-3082	31	7	with	with	ADP
ijpds-3082	31	8	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	31	9	.	.	PUNCT
ijpds-3082	32	1	on	on	ADP
ijpds-3082	32	2	cutaneous	cutaneous	ADJ
ijpds-3082	32	3	clinical	clinical	ADJ
ijpds-3082	32	4	examination	examination	NOUN
ijpds-3082	32	5	,	,	PUNCT
ijpds-3082	32	6	it	it	PRON
ijpds-3082	32	7	revealed	reveal	VERB
ijpds-3082	32	8	a	a	DET
ijpds-3082	32	9	severe	severe	ADJ
ijpds-3082	32	10	infective	infective	ADJ
ijpds-3082	32	11	mass	mass	NOUN
ijpds-3082	32	12	tumor	tumor	NOUN
ijpds-3082	32	13	(	(	PUNCT
ijpds-3082	32	14	fig	fig	NOUN
ijpds-3082	32	15	.	.	NOUN
ijpds-3082	32	16	1	1	NUM
ijpds-3082	32	17	)	)	PUNCT
ijpds-3082	32	18	over	over	ADP
ijpds-3082	32	19	the	the	DET
ijpds-3082	32	20	left	left	ADJ
ijpds-3082	32	21	forearm	forearm	NOUN
ijpds-3082	32	22	,	,	PUNCT
ijpds-3082	32	23	the	the	DET
ijpds-3082	32	24	biopsy	biopsy	NOUN
ijpds-3082	32	25	was	be	AUX
ijpds-3082	32	26	not	not	PART
ijpds-3082	32	27	performed	perform	VERB
ijpds-3082	32	28	.	.	PUNCT
ijpds-3082	33	1	associated	associated	ADJ
ijpds-3082	33	2	pruritus	pruritus	PROPN
ijpds-3082	33	3	that	that	PRON
ijpds-3082	33	4	was	be	AUX
ijpds-3082	33	5	generalized	generalize	VERB
ijpds-3082	33	6	moderate	moderate	ADJ
ijpds-3082	33	7	to	to	PART
ijpds-3082	33	8	severe	severe	ADJ
ijpds-3082	33	9	in	in	ADP
ijpds-3082	33	10	intensity	intensity	NOUN
ijpds-3082	33	11	with	with	ADP
ijpds-3082	33	12	no	no	DET
ijpds-3082	33	13	diurnal	diurnal	ADJ
ijpds-3082	33	14	variation	variation	NOUN
ijpds-3082	33	15	and	and	CCONJ
ijpds-3082	33	16	relieved	relieve	VERB
ijpds-3082	33	17	by	by	ADP
ijpds-3082	33	18	treatment	treatment	NOUN
ijpds-3082	33	19	with	with	ADP
ijpds-3082	33	20	oral	oral	ADJ
ijpds-3082	33	21	anti	anti	ADJ
ijpds-3082	33	22	-	-	ADJ
ijpds-3082	33	23	histamines	histamine	NOUN
ijpds-3082	33	24	and	and	CCONJ
ijpds-3082	33	25	topical	topical	ADJ
ijpds-3082	33	26	calamine	calamine	NOUN
ijpds-3082	33	27	lotion	lotion	NOUN
ijpds-3082	33	28	.	.	PUNCT
ijpds-3082	34	1	on	on	ADP
ijpds-3082	34	2	physical	physical	ADJ
ijpds-3082	34	3	examination	examination	NOUN
ijpds-3082	34	4	,	,	PUNCT
ijpds-3082	34	5	the	the	DET
ijpds-3082	34	6	patient	patient	NOUN
ijpds-3082	34	7	have	have	VERB
ijpds-3082	34	8	a	a	DET
ijpds-3082	34	9	high	high	ADJ
ijpds-3082	34	10	blood	blood	NOUN
ijpds-3082	34	11	pressure	pressure	NOUN
ijpds-3082	34	12	of	of	ADP
ijpds-3082	34	13	170/90	170/90	NUM
ijpds-3082	34	14	mmhg	mmhg	NOUN
ijpds-3082	34	15	that	that	PRON
ijpds-3082	34	16	was	be	AUX
ijpds-3082	34	17	newly	newly	ADV
ijpds-3082	34	18	diagnosed	diagnose	VERB
ijpds-3082	34	19	.	.	PUNCT
ijpds-3082	35	1	on	on	ADP
ijpds-3082	35	2	laboratory	laboratory	NOUN
ijpds-3082	35	3	investigation	investigation	NOUN
ijpds-3082	35	4	,	,	PUNCT
ijpds-3082	35	5	c	c	NOUN
ijpds-3082	35	6	-	-	ADJ
ijpds-3082	35	7	reactive	reactive	ADJ
ijpds-3082	35	8	protein	protein	NOUN
ijpds-3082	35	9	values	value	NOUN
ijpds-3082	35	10	found	find	VERB
ijpds-3082	35	11	to	to	PART
ijpds-3082	35	12	be	be	AUX
ijpds-3082	35	13	increased	increase	VERB
ijpds-3082	35	14	18mg	18mg	ADV
ijpds-3082	35	15	/	/	SYM
ijpds-3082	35	16	l	l	NOUN
ijpds-3082	35	17	(	(	PUNCT
ijpds-3082	35	18	0.310mg	0.310mg	PROPN
ijpds-3082	35	19	/	/	SYM
ijpds-3082	35	20	l	l	NOUN
ijpds-3082	35	21	)	)	PUNCT
ijpds-3082	35	22	.	.	PUNCT
ijpds-3082	36	1	the	the	DET
ijpds-3082	36	2	patient	patient	NOUN
ijpds-3082	36	3	was	be	AUX
ijpds-3082	36	4	admitted	admit	VERB
ijpds-3082	36	5	to	to	ADP
ijpds-3082	36	6	the	the	DET
ijpds-3082	36	7	n	n	NUM
ijpds-3082	36	8	mailto:spadmakar717@gmail.com	mailto:spadmakar717@gmail.com	X
ijpds-3082	36	9	padmakar	padmakar	NOUN
ijpds-3082	36	10	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	36	11	associated	associate	VERB
ijpds-3082	36	12	with	with	ADP
ijpds-3082	36	13	infective	infective	ADJ
ijpds-3082	36	14	mass	mass	NOUN
ijpds-3082	36	15	tumor	tumor	NOUN
ijpds-3082	36	16	vol	vol	NOUN
ijpds-3082	36	17	1	1	NUM
ijpds-3082	36	18	|	|	NOUN
ijpds-3082	36	19	issue	issue	NOUN
ijpds-3082	36	20	2	2	NUM
ijpds-3082	37	1	|	|	ADV
ijpds-3082	37	2	jul	jul	PROPN
ijpds-3082	37	3	–	–	PUNCT
ijpds-3082	37	4	sep	sep	PROPN
ijpds-3082	37	5	2022	2022	NUM
ijpds-3082	37	6	indian	indian	PROPN
ijpds-3082	37	7	j	j	PROPN
ijpds-3082	37	8	pharm	pharm	PROPN
ijpds-3082	37	9	drug	drug	PROPN
ijpds-3082	37	10	studies	study	NOUN
ijpds-3082	37	11	|	|	ADV
ijpds-3082	37	12	70	70	NUM
ijpds-3082	37	13	hospital	hospital	NOUN
ijpds-3082	37	14	for	for	ADP
ijpds-3082	37	15	seven	seven	NUM
ijpds-3082	37	16	days	day	NOUN
ijpds-3082	37	17	and	and	CCONJ
ijpds-3082	37	18	treated	treat	VERB
ijpds-3082	37	19	with	with	ADP
ijpds-3082	37	20	medications	medication	NOUN
ijpds-3082	37	21	shown	show	VERB
ijpds-3082	37	22	in	in	ADP
ijpds-3082	37	23	table	table	NOUN
ijpds-3082	37	24	1	1	NUM
ijpds-3082	37	25	.	.	PUNCT
ijpds-3082	38	1	after	after	ADP
ijpds-3082	38	2	seven	seven	NUM
ijpds-3082	38	3	days	day	NOUN
ijpds-3082	38	4	the	the	DET
ijpds-3082	38	5	patient	patient	NOUN
ijpds-3082	38	6	was	be	AUX
ijpds-3082	38	7	discharged	discharge	VERB
ijpds-3082	38	8	with	with	ADP
ijpds-3082	38	9	the	the	DET
ijpds-3082	38	10	following	follow	VERB
ijpds-3082	38	11	medications	medication	NOUN
ijpds-3082	38	12	tab	tab	NOUN
ijpds-3082	38	13	.	.	PUNCT
ijpds-3082	39	1	amoxycillin	amoxycillin	NOUN
ijpds-3082	39	2	and	and	CCONJ
ijpds-3082	39	3	potassium	potassium	NOUN
ijpds-3082	39	4	clavulanate	clavulanate	NOUN
ijpds-3082	39	5	625	625	NUM
ijpds-3082	39	6	mg	mg	PROPN
ijpds-3082	39	7	,	,	PUNCT
ijpds-3082	39	8	oint	oint	PROPN
ijpds-3082	39	9	.	.	PUNCT
ijpds-3082	40	1	fusidic	fusidic	ADJ
ijpds-3082	40	2	acid	acid	PROPN
ijpds-3082	40	3	2	2	NUM
ijpds-3082	40	4	%	%	NOUN
ijpds-3082	40	5	,	,	PUNCT
ijpds-3082	40	6	tab	tab	NOUN
ijpds-3082	40	7	.	.	PUNCT
ijpds-3082	40	8	chlorpheniramine	chlorpheniramine	PROPN
ijpds-3082	40	9	maleate	maleate	NOUN
ijpds-3082	40	10	2	2	NUM
ijpds-3082	40	11	mg	mg	NOUN
ijpds-3082	40	12	od	od	NOUN
ijpds-3082	40	13	and	and	CCONJ
ijpds-3082	40	14	asked	ask	VERB
ijpds-3082	40	15	to	to	PART
ijpds-3082	40	16	review	review	VERB
ijpds-3082	40	17	for	for	ADP
ijpds-3082	40	18	surgery	surgery	NOUN
ijpds-3082	40	19	after	after	ADP
ijpds-3082	40	20	1	1	NUM
ijpds-3082	40	21	week	week	NOUN
ijpds-3082	40	22	fig	fig	NOUN
ijpds-3082	40	23	.	.	PUNCT
ijpds-3082	41	1	1	1	NUM
ijpds-3082	41	2	neurofibromas	neurofibroma	NOUN
ijpds-3082	41	3	associated	associate	VERB
ijpds-3082	41	4	with	with	ADP
ijpds-3082	41	5	infective	infective	ADJ
ijpds-3082	41	6	mass	mass	ADJ
ijpds-3082	41	7	tumor	tumor	NOUN
ijpds-3082	41	8	over	over	ADP
ijpds-3082	41	9	left	left	ADJ
ijpds-3082	41	10	forearm	forearm	NOUN
ijpds-3082	41	11	table	table	NOUN
ijpds-3082	41	12	1	1	NUM
ijpds-3082	41	13	:	:	PUNCT
ijpds-3082	41	14	drugs	drug	NOUN
ijpds-3082	41	15	prescribed	prescribe	VERB
ijpds-3082	41	16	to	to	ADP
ijpds-3082	41	17	the	the	DET
ijpds-3082	41	18	patient	patient	ADJ
ijpds-3082	41	19	drug	drug	NOUN
ijpds-3082	41	20	name	name	NOUN
ijpds-3082	41	21	dose	dose	NOUN
ijpds-3082	41	22	route	route	NOUN
ijpds-3082	41	23	freque	freque	NOUN
ijpds-3082	41	24	ncy	ncy	PROPN
ijpds-3082	41	25	dura	dura	PROPN
ijpds-3082	41	26	tion	tion	PROPN
ijpds-3082	41	27	inj	inj	PROPN
ijpds-3082	41	28	.	.	PUNCT
ijpds-3082	42	1	amoxycillin	amoxycillin	PROPN
ijpds-3082	42	2	and	and	CCONJ
ijpds-3082	42	3	potassium	potassium	NOUN
ijpds-3082	42	4	clavulanate	clavulanate	NOUN
ijpds-3082	42	5	1.2	1.2	NUM
ijpds-3082	42	6	g	g	NOUN
ijpds-3082	42	7	iv	iv	NUM
ijpds-3082	42	8	bid	bid	NOUN
ijpds-3082	42	9	6	6	NUM
ijpds-3082	42	10	d	d	NOUN
ijpds-3082	42	11	inj	inj	NOUN
ijpds-3082	42	12	.	.	PUNCT
ijpds-3082	43	1	diclofenac	diclofenac	NOUN
ijpds-3082	43	2	sodium	sodium	NOUN
ijpds-3082	43	3	75	75	NUM
ijpds-3082	43	4	mg	mg	NOUN
ijpds-3082	43	5	iv	iv	NUM
ijpds-3082	43	6	bid	bid	VERB
ijpds-3082	43	7	4	4	NUM
ijpds-3082	43	8	d	d	NOUN
ijpds-3082	43	9	inj	inj	NOUN
ijpds-3082	43	10	.	.	PUNCT
ijpds-3082	44	1	pantoprazole	pantoprazole	PROPN
ijpds-3082	44	2	40	40	NUM
ijpds-3082	44	3	mg	mg	NOUN
ijpds-3082	44	4	iv	iv	NUM
ijpds-3082	44	5	bid	bid	VERB
ijpds-3082	44	6	6	6	NUM
ijpds-3082	44	7	d	d	PROPN
ijpds-3082	44	8	oint	oint	PROPN
ijpds-3082	44	9	.	.	PUNCT
ijpds-3082	45	1	fusidic	fusidic	ADJ
ijpds-3082	45	2	acid	acid	NOUN
ijpds-3082	45	3	2	2	NUM
ijpds-3082	45	4	%	%	NOUN
ijpds-3082	45	5	w	w	PROPN
ijpds-3082	45	6	/	/	SYM
ijpds-3082	45	7	w	w	NOUN
ijpds-3082	45	8	topical	topical	ADJ
ijpds-3082	45	9	tid	tid	NOUN
ijpds-3082	45	10	7	7	NUM
ijpds-3082	45	11	d	d	PROPN
ijpds-3082	45	12	tab	tab	PROPN
ijpds-3082	45	13	.	.	PUNCT
ijpds-3082	46	1	chlorpheniramine	chlorpheniramine	PROPN
ijpds-3082	46	2	ma	ma	PROPN
ijpds-3082	46	3	4	4	NUM
ijpds-3082	46	4	mg	mg	PROPN
ijpds-3082	46	5	oral	oral	NOUN
ijpds-3082	46	6	od	od	PROPN
ijpds-3082	46	7	6	6	NUM
ijpds-3082	46	8	d	d	NOUN
ijpds-3082	46	9	note	note	NOUN
ijpds-3082	46	10	:	:	PUNCT
ijpds-3082	46	11	iv	iv	NUM
ijpds-3082	46	12	intravenous	intravenous	ADJ
ijpds-3082	46	13	bid	bid	NOUN
ijpds-3082	46	14	-	-	PUNCT
ijpds-3082	46	15	twice	twice	DET
ijpds-3082	46	16	a	a	DET
ijpds-3082	46	17	day	day	NOUN
ijpds-3082	46	18	;	;	PUNCT
ijpds-3082	46	19	tid	tid	NOUN
ijpds-3082	46	20	-	-	PUNCT
ijpds-3082	46	21	three	three	NUM
ijpds-3082	46	22	times	time	NOUN
ijpds-3082	46	23	a	a	DET
ijpds-3082	46	24	day	day	NOUN
ijpds-3082	46	25	;	;	PUNCT
ijpds-3082	46	26	od	od	X
ijpds-3082	46	27	-	-	PUNCT
ijpds-3082	46	28	once	once	ADV
ijpds-3082	46	29	a	a	DET
ijpds-3082	46	30	day	day	NOUN
ijpds-3082	46	31	discussion	discussion	NOUN
ijpds-3082	46	32	nf1	nf1	NOUN
ijpds-3082	46	33	is	be	AUX
ijpds-3082	46	34	an	an	DET
ijpds-3082	46	35	inherited	inherit	VERB
ijpds-3082	46	36	neurocutaneous	neurocutaneous	ADJ
ijpds-3082	46	37	condition	condition	NOUN
ijpds-3082	46	38	and	and	CCONJ
ijpds-3082	46	39	characterized	characterize	VERB
ijpds-3082	46	40	by	by	ADP
ijpds-3082	46	41	a	a	DET
ijpds-3082	46	42	multi	multi	ADJ
ijpds-3082	46	43	-	-	ADJ
ijpds-3082	46	44	system	system	ADJ
ijpds-3082	46	45	tumor	tumor	NOUN
ijpds-3082	46	46	with	with	ADP
ijpds-3082	46	47	a	a	DET
ijpds-3082	46	48	risk	risk	NOUN
ijpds-3082	46	49	of	of	ADP
ijpds-3082	46	50	malignant	malignant	ADJ
ijpds-3082	46	51	transformation	transformation	NOUN
ijpds-3082	46	52	across	across	ADP
ijpds-3082	46	53	the	the	DET
ijpds-3082	46	54	skin	skin	NOUN
ijpds-3082	46	55	in	in	ADP
ijpds-3082	46	56	the	the	DET
ijpds-3082	46	57	central	central	ADJ
ijpds-3082	46	58	nervous	nervous	ADJ
ijpds-3082	46	59	system	system	NOUN
ijpds-3082	46	60	.	.	PUNCT
ijpds-3082	47	1	neurofibromas	neurofibroma	NOUN
ijpds-3082	47	2	are	be	AUX
ijpds-3082	47	3	a	a	DET
ijpds-3082	47	4	distinctive	distinctive	ADJ
ijpds-3082	47	5	feature	feature	NOUN
ijpds-3082	47	6	of	of	ADP
ijpds-3082	47	7	the	the	DET
ijpds-3082	47	8	nf1	nf1	NOUN
ijpds-3082	47	9	,	,	PUNCT
ijpds-3082	47	10	which	which	PRON
ijpds-3082	47	11	are	be	AUX
ijpds-3082	47	12	benign	benign	ADJ
ijpds-3082	47	13	tissue	tissue	NOUN
ijpds-3082	47	14	-	-	PUNCT
ijpds-3082	47	15	based	base	VERB
ijpds-3082	47	16	tumors	tumor	NOUN
ijpds-3082	47	17	that	that	PRON
ijpds-3082	47	18	occur	occur	VERB
ijpds-3082	47	19	at	at	ADP
ijpds-3082	47	20	the	the	DET
ijpds-3082	47	21	periphery	periphery	NOUN
ijpds-3082	47	22	of	of	ADP
ijpds-3082	47	23	the	the	DET
ijpds-3082	47	24	nerves	nerve	NOUN
ijpds-3082	47	25	of	of	ADP
ijpds-3082	47	26	schwann	schwann	PROPN
ijpds-3082	47	27	cells	cell	NOUN
ijpds-3082	47	28	.	.	PUNCT
ijpds-3082	48	1	they	they	PRON
ijpds-3082	48	2	comprise	comprise	VERB
ijpds-3082	48	3	fibroblasts	fibroblast	NOUN
ijpds-3082	48	4	,	,	PUNCT
ijpds-3082	48	5	macrophages	macrophage	NOUN
ijpds-3082	48	6	,	,	PUNCT
ijpds-3082	48	7	and	and	CCONJ
ijpds-3082	48	8	mast	mast	NOUN
ijpds-3082	48	9	cells	cell	NOUN
ijpds-3082	48	10	in	in	ADP
ijpds-3082	48	11	addition	addition	NOUN
ijpds-3082	48	12	to	to	ADP
ijpds-3082	48	13	neoplastic	neoplastic	ADJ
ijpds-3082	48	14	schwann	schwann	ADJ
ijpds-3082	48	15	cells	cell	NOUN
ijpds-3082	48	16	[	[	X
ijpds-3082	48	17	6	6	NUM
ijpds-3082	48	18	]	]	PUNCT
ijpds-3082	48	19	.	.	PUNCT
ijpds-3082	49	1	52.5	52.5	NUM
ijpds-3082	49	2	%	%	NOUN
ijpds-3082	49	3	of	of	ADP
ijpds-3082	49	4	individuals	individual	NOUN
ijpds-3082	49	5	with	with	ADP
ijpds-3082	49	6	pruritus	pruritus	PROPN
ijpds-3082	49	7	had	have	AUX
ijpds-3082	49	8	localized	localize	VERB
ijpds-3082	49	9	in	in	ADP
ijpds-3082	49	10	one	one	NUM
ijpds-3082	49	11	or	or	CCONJ
ijpds-3082	49	12	more	more	ADV
ijpds-3082	49	13	cutaneous	cutaneous	ADJ
ijpds-3082	49	14	neurofibromas	neurofibroma	NOUN
ijpds-3082	49	15	.	.	PUNCT
ijpds-3082	50	1	pruritus	pruritus	PROPN
ijpds-3082	50	2	pathogenesis	pathogenesis	NOUN
ijpds-3082	50	3	is	be	AUX
ijpds-3082	50	4	not	not	PART
ijpds-3082	50	5	well	well	ADV
ijpds-3082	50	6	known	know	VERB
ijpds-3082	50	7	in	in	ADP
ijpds-3082	50	8	nf1	nf1	NOUN
ijpds-3082	50	9	.	.	PUNCT
ijpds-3082	51	1	it	it	PRON
ijpds-3082	51	2	hypothesized	hypothesize	VERB
ijpds-3082	51	3	that	that	SCONJ
ijpds-3082	51	4	mast	mast	NOUN
ijpds-3082	51	5	cells	cell	NOUN
ijpds-3082	51	6	and	and	CCONJ
ijpds-3082	51	7	components	component	NOUN
ijpds-3082	51	8	produced	produce	VERB
ijpds-3082	51	9	from	from	ADP
ijpds-3082	51	10	their	their	PRON
ijpds-3082	51	11	degranulation	degranulation	NOUN
ijpds-3082	51	12	were	be	AUX
ijpds-3082	51	13	considered	consider	VERB
ijpds-3082	51	14	the	the	DET
ijpds-3082	51	15	main	main	ADJ
ijpds-3082	51	16	source	source	NOUN
ijpds-3082	51	17	of	of	ADP
ijpds-3082	51	18	pruritus	pruritus	PROPN
ijpds-3082	51	19	,	,	PUNCT
ijpds-3082	51	20	cnf	cnf	PROPN
ijpds-3082	51	21	microenvironment	microenvironment	NOUN
ijpds-3082	51	22	was	be	AUX
ijpds-3082	51	23	known	know	VERB
ijpds-3082	51	24	to	to	PART
ijpds-3082	51	25	have	have	VERB
ijpds-3082	51	26	mast	mast	NOUN
ijpds-3082	51	27	cells	cell	NOUN
ijpds-3082	51	28	,	,	PUNCT
ijpds-3082	51	29	which	which	PRON
ijpds-3082	51	30	may	may	AUX
ijpds-3082	51	31	contribute	contribute	VERB
ijpds-3082	51	32	to	to	ADP
ijpds-3082	51	33	tumor	tumor	NOUN
ijpds-3082	51	34	initiation	initiation	NOUN
ijpds-3082	51	35	,	,	PUNCT
ijpds-3082	51	36	progression	progression	NOUN
ijpds-3082	51	37	,	,	PUNCT
ijpds-3082	51	38	and	and	CCONJ
ijpds-3082	51	39	angiogenesis	angiogenesis	NOUN
ijpds-3082	52	1	[	[	X
ijpds-3082	52	2	7	7	NUM
ijpds-3082	52	3	]	]	PUNCT
ijpds-3082	52	4	.	.	PUNCT
ijpds-3082	53	1	type	type	NOUN
ijpds-3082	53	2	1	1	NUM
ijpds-3082	53	3	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	53	4	is	be	AUX
ijpds-3082	53	5	described	describe	VERB
ijpds-3082	53	6	as	as	ADP
ijpds-3082	53	7	a	a	DET
ijpds-3082	53	8	benign	benign	ADJ
ijpds-3082	53	9	tumor	tumor	NOUN
ijpds-3082	53	10	disorder	disorder	NOUN
ijpds-3082	53	11	nevertheless	nevertheless	ADV
ijpds-3082	53	12	,	,	PUNCT
ijpds-3082	53	13	in	in	ADP
ijpds-3082	53	14	2	2	NUM
ijpds-3082	53	15	%	%	NOUN
ijpds-3082	53	16	or	or	CCONJ
ijpds-3082	53	17	4.2	4.2	NUM
ijpds-3082	53	18	%	%	NOUN
ijpds-3082	53	19	of	of	ADP
ijpds-3082	53	20	patients	patient	NOUN
ijpds-3082	53	21	older	old	ADJ
ijpds-3082	53	22	than	than	ADP
ijpds-3082	53	23	21	21	NUM
ijpds-3082	53	24	years	year	NOUN
ijpds-3082	53	25	malignant	malignant	ADJ
ijpds-3082	53	26	transformation	transformation	NOUN
ijpds-3082	53	27	was	be	AUX
ijpds-3082	53	28	reported	report	VERB
ijpds-3082	53	29	[	[	X
ijpds-3082	53	30	8	8	NUM
ijpds-3082	53	31	]	]	PUNCT
ijpds-3082	53	32	.	.	PUNCT
ijpds-3082	54	1	there	there	PRON
ijpds-3082	54	2	is	be	VERB
ijpds-3082	54	3	currently	currently	ADV
ijpds-3082	54	4	no	no	DET
ijpds-3082	54	5	effective	effective	ADJ
ijpds-3082	54	6	treatment	treatment	NOUN
ijpds-3082	54	7	method	method	NOUN
ijpds-3082	54	8	for	for	ADP
ijpds-3082	54	9	people	people	NOUN
ijpds-3082	54	10	with	with	ADP
ijpds-3082	54	11	type	type	NOUN
ijpds-3082	54	12	1	1	NUM
ijpds-3082	54	13	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	54	14	.	.	PUNCT
ijpds-3082	55	1	one	one	NUM
ijpds-3082	55	2	approach	approach	NOUN
ijpds-3082	55	3	is	be	AUX
ijpds-3082	55	4	surgical	surgical	ADJ
ijpds-3082	55	5	excision	excision	NOUN
ijpds-3082	55	6	,	,	PUNCT
ijpds-3082	55	7	although	although	SCONJ
ijpds-3082	55	8	it	it	PRON
ijpds-3082	55	9	is	be	AUX
ijpds-3082	55	10	usually	usually	ADV
ijpds-3082	55	11	impossible	impossible	ADJ
ijpds-3082	55	12	to	to	PART
ijpds-3082	55	13	remove	remove	VERB
ijpds-3082	55	14	all	all	DET
ijpds-3082	55	15	lesions	lesion	NOUN
ijpds-3082	55	16	due	due	ADJ
ijpds-3082	55	17	to	to	ADP
ijpds-3082	55	18	excess	excess	NOUN
ijpds-3082	55	19	of	of	ADP
ijpds-3082	55	20	nf-1	nf-1	NUM
ijpds-3082	55	21	and	and	CCONJ
ijpds-3082	55	22	the	the	DET
ijpds-3082	55	23	progression	progression	NOUN
ijpds-3082	55	24	of	of	ADP
ijpds-3082	55	25	the	the	DET
ijpds-3082	55	26	disease	disease	NOUN
ijpds-3082	55	27	.	.	PUNCT
ijpds-3082	56	1	surgery	surgery	NOUN
ijpds-3082	56	2	is	be	AUX
ijpds-3082	56	3	required	require	VERB
ijpds-3082	56	4	when	when	SCONJ
ijpds-3082	56	5	suspected	suspect	VERB
ijpds-3082	56	6	of	of	ADP
ijpds-3082	56	7	malignancy	malignancy	NOUN
ijpds-3082	56	8	.	.	PUNCT
ijpds-3082	57	1	operation	operation	NOUN
ijpds-3082	57	2	indicated	indicate	VERB
ijpds-3082	57	3	if	if	SCONJ
ijpds-3082	57	4	tumors	tumor	NOUN
ijpds-3082	57	5	pressure	pressure	VERB
ijpds-3082	57	6	on	on	ADP
ijpds-3082	57	7	other	other	ADJ
ijpds-3082	57	8	organs	organ	NOUN
ijpds-3082	57	9	[	[	X
ijpds-3082	57	10	9	9	NUM
ijpds-3082	57	11	]	]	PUNCT
ijpds-3082	57	12	.	.	PUNCT
ijpds-3082	58	1	in	in	ADP
ijpds-3082	58	2	preoperative	preoperative	ADJ
ijpds-3082	58	3	,	,	PUNCT
ijpds-3082	58	4	perioperative	perioperative	ADJ
ijpds-3082	58	5	,	,	PUNCT
ijpds-3082	58	6	and	and	CCONJ
ijpds-3082	58	7	postoperative	postoperative	ADJ
ijpds-3082	58	8	conditions	condition	NOUN
ijpds-3082	58	9	,	,	PUNCT
ijpds-3082	58	10	radiation	radiation	NOUN
ijpds-3082	58	11	treatment	treatment	NOUN
ijpds-3082	58	12	is	be	AUX
ijpds-3082	58	13	used	use	VERB
ijpds-3082	58	14	.	.	PUNCT
ijpds-3082	59	1	adjuvant	adjuvant	ADJ
ijpds-3082	59	2	radiation	radiation	NOUN
ijpds-3082	59	3	treatment	treatment	NOUN
ijpds-3082	59	4	produced	produce	VERB
ijpds-3082	59	5	a	a	DET
ijpds-3082	59	6	statistically	statistically	ADV
ijpds-3082	59	7	significant	significant	ADJ
ijpds-3082	59	8	decrease	decrease	NOUN
ijpds-3082	59	9	in	in	ADP
ijpds-3082	59	10	rates	rate	NOUN
ijpds-3082	59	11	of	of	ADP
ijpds-3082	59	12	recurrence	recurrence	NOUN
ijpds-3082	59	13	of	of	ADP
ijpds-3082	59	14	local	local	ADJ
ijpds-3082	59	15	diseases	disease	NOUN
ijpds-3082	59	16	[	[	X
ijpds-3082	59	17	10	10	NUM
ijpds-3082	59	18	]	]	PUNCT
ijpds-3082	59	19	.	.	PUNCT
ijpds-3082	60	1	conclusion	conclusion	NOUN
ijpds-3082	60	2	benign	benign	ADJ
ijpds-3082	60	3	(	(	PUNCT
ijpds-3082	60	4	harmless	harmless	ADJ
ijpds-3082	60	5	)	)	PUNCT
ijpds-3082	60	6	tumors	tumor	NOUN
ijpds-3082	60	7	of	of	ADP
ijpds-3082	60	8	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	60	9	do	do	AUX
ijpds-3082	60	10	not	not	PART
ijpds-3082	60	11	need	need	VERB
ijpds-3082	60	12	treatment	treatment	NOUN
ijpds-3082	60	13	.	.	PUNCT
ijpds-3082	61	1	but	but	CCONJ
ijpds-3082	61	2	subcutaneous	subcutaneous	ADJ
ijpds-3082	61	3	tissues	tissue	NOUN
ijpds-3082	61	4	are	be	AUX
ijpds-3082	61	5	often	often	ADV
ijpds-3082	61	6	affected	affect	VERB
ijpds-3082	61	7	by	by	ADP
ijpds-3082	61	8	superficial	superficial	ADJ
ijpds-3082	61	9	tumors	tumor	NOUN
ijpds-3082	61	10	and	and	CCONJ
ijpds-3082	61	11	may	may	AUX
ijpds-3082	61	12	evoke	evoke	VERB
ijpds-3082	61	13	significant	significant	ADJ
ijpds-3082	61	14	infection	infection	NOUN
ijpds-3082	61	15	or	or	CCONJ
ijpds-3082	61	16	cellulitis	cellulitis	NOUN
ijpds-3082	61	17	.	.	PUNCT
ijpds-3082	62	1	the	the	DET
ijpds-3082	62	2	dermatologist	dermatologist	NOUN
ijpds-3082	62	3	,	,	PUNCT
ijpds-3082	62	4	neurologist	neurologist	NOUN
ijpds-3082	62	5	,	,	PUNCT
ijpds-3082	62	6	and	and	CCONJ
ijpds-3082	62	7	general	general	ADJ
ijpds-3082	62	8	surgeon	surgeon	NOUN
ijpds-3082	62	9	should	should	AUX
ijpds-3082	62	10	follow	follow	VERB
ijpds-3082	62	11	these	these	DET
ijpds-3082	62	12	patients	patient	NOUN
ijpds-3082	62	13	routinely	routinely	ADV
ijpds-3082	62	14	to	to	PART
ijpds-3082	62	15	ensure	ensure	VERB
ijpds-3082	62	16	no	no	DET
ijpds-3082	62	17	mass	mass	NOUN
ijpds-3082	62	18	lesions	lesion	NOUN
ijpds-3082	62	19	were	be	AUX
ijpds-3082	62	20	developing	develop	VERB
ijpds-3082	62	21	.	.	PUNCT
ijpds-3082	63	1	note	note	NOUN
ijpds-3082	63	2	:	:	PUNCT
ijpds-3082	63	3	written	write	VERB
ijpds-3082	63	4	informed	informed	ADJ
ijpds-3082	63	5	consent	consent	NOUN
ijpds-3082	63	6	was	be	AUX
ijpds-3082	63	7	taken	take	VERB
ijpds-3082	63	8	from	from	ADP
ijpds-3082	63	9	the	the	DET
ijpds-3082	63	10	patient	patient	NOUN
ijpds-3082	63	11	who	who	PRON
ijpds-3082	63	12	participated	participate	VERB
ijpds-3082	63	13	in	in	ADP
ijpds-3082	63	14	this	this	DET
ijpds-3082	63	15	study	study	NOUN
ijpds-3082	63	16	.	.	PUNCT
ijpds-3082	64	1	references	reference	NOUN
ijpds-3082	64	2	1	1	NUM
ijpds-3082	64	3	.	.	PUNCT
ijpds-3082	64	4	north	north	NOUN
ijpds-3082	64	5	k.	k.	PROPN
ijpds-3082	64	6	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	64	7	type	type	NOUN
ijpds-3082	64	8	1	1	NUM
ijpds-3082	64	9	.	.	PUNCT
ijpds-3082	64	10	am	be	AUX
ijpds-3082	64	11	j	j	PROPN
ijpds-3082	64	12	med	med	PROPN
ijpds-3082	64	13	genet	genet	PROPN
ijpds-3082	64	14	.	.	PUNCT
ijpds-3082	65	1	2000	2000	NUM
ijpds-3082	65	2	;	;	PUNCT
ijpds-3082	66	1	97(2):119	97(2):119	NUM
ijpds-3082	66	2	-	-	SYM
ijpds-3082	66	3	127	127	NUM
ijpds-3082	66	4	.	.	PUNCT
ijpds-3082	67	1	2	2	X
ijpds-3082	67	2	.	.	X
ijpds-3082	67	3	nallanchakrava	nallanchakrava	PROPN
ijpds-3082	67	4	s	s	PROPN
ijpds-3082	67	5	,	,	PUNCT
ijpds-3082	67	6	mallela	mallela	PROPN
ijpds-3082	67	7	mk	mk	PROPN
ijpds-3082	67	8	,	,	PUNCT
ijpds-3082	67	9	jeenepalli	jeenepalli	PROPN
ijpds-3082	67	10	vs	vs	ADP
ijpds-3082	67	11	,	,	PUNCT
ijpds-3082	67	12	et	et	PROPN
ijpds-3082	67	13	al	al	PROPN
ijpds-3082	67	14	.	.	PUNCT
ijpds-3082	68	1	a	a	DET
ijpds-3082	68	2	rare	rare	ADJ
ijpds-3082	68	3	case	case	NOUN
ijpds-3082	68	4	report	report	NOUN
ijpds-3082	68	5	of	of	ADP
ijpds-3082	68	6	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	68	7	type	type	NOUN
ijpds-3082	68	8	1	1	NUM
ijpds-3082	68	9	in	in	ADP
ijpds-3082	68	10	a	a	DET
ijpds-3082	68	11	12	12	NUM
ijpds-3082	68	12	-	-	PUNCT
ijpds-3082	68	13	year	year	NOUN
ijpds-3082	68	14	-	-	PUNCT
ijpds-3082	68	15	old	old	ADJ
ijpds-3082	68	16	child	child	NOUN
ijpds-3082	68	17	:	:	PUNCT
ijpds-3082	68	18	a	a	DET
ijpds-3082	68	19	15month	15month	NUM
ijpds-3082	68	20	follow	follow	NOUN
ijpds-3082	68	21	-	-	PUNCT
ijpds-3082	68	22	up	up	NOUN
ijpds-3082	68	23	.	.	PUNCT
ijpds-3082	69	1	j	j	PROPN
ijpds-3082	69	2	oral	oral	ADJ
ijpds-3082	69	3	maxillofacial	maxillofacial	ADJ
ijpds-3082	69	4	pathol	pathol	NOUN
ijpds-3082	69	5	.	.	PUNCT
ijpds-3082	70	1	2020	2020	NUM
ijpds-3082	70	2	;	;	PUNCT
ijpds-3082	70	3	24:106	24:106	NUM
ijpds-3082	70	4	-	-	SYM
ijpds-3082	70	5	109	109	NUM
ijpds-3082	70	6	.	.	PUNCT
ijpds-3082	71	1	3	3	X
ijpds-3082	71	2	.	.	X
ijpds-3082	71	3	rasmussen	rasmussen	PROPN
ijpds-3082	71	4	sa	sa	PROPN
ijpds-3082	71	5	,	,	PUNCT
ijpds-3082	71	6	overman	overman	PROPN
ijpds-3082	71	7	j	j	PROPN
ijpds-3082	71	8	,	,	PUNCT
ijpds-3082	71	9	thomson	thomson	PROPN
ijpds-3082	71	10	sa	sa	PROPN
ijpds-3082	71	11	,	,	PUNCT
ijpds-3082	71	12	et	et	PROPN
ijpds-3082	71	13	al	al	PROPN
ijpds-3082	71	14	.	.	PROPN
ijpds-3082	71	15	chromosome	chromosome	PROPN
ijpds-3082	71	16	17	17	NUM
ijpds-3082	71	17	loss‐of‐heterozygosity	loss‐of‐heterozygosity	NOUN
ijpds-3082	71	18	studies	study	NOUN
ijpds-3082	71	19	in	in	ADP
ijpds-3082	71	20	benign	benign	ADJ
ijpds-3082	71	21	and	and	CCONJ
ijpds-3082	71	22	malignant	malignant	ADJ
ijpds-3082	71	23	tumors	tumor	NOUN
ijpds-3082	71	24	in	in	ADP
ijpds-3082	71	25	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	71	26	type	type	NOUN
ijpds-3082	71	27	1	1	NUM
ijpds-3082	71	28	.	.	PUNCT
ijpds-3082	72	1	genes	gene	NOUN
ijpds-3082	72	2	chromosomes	chromosome	NOUN
ijpds-3082	72	3	cancer	cancer	NOUN
ijpds-3082	72	4	.	.	PUNCT
ijpds-3082	73	1	2000	2000	NUM
ijpds-3082	73	2	;	;	PUNCT
ijpds-3082	73	3	28(4):425	28(4):425	NOUN
ijpds-3082	73	4	-	-	PUNCT
ijpds-3082	73	5	431	431	NUM
ijpds-3082	73	6	.	.	PUNCT
ijpds-3082	74	1	4	4	X
ijpds-3082	74	2	.	.	X
ijpds-3082	74	3	bergqvist	bergqvist	PROPN
ijpds-3082	74	4	c	c	PROPN
ijpds-3082	74	5	,	,	PUNCT
ijpds-3082	74	6	servy	servy	PROPN
ijpds-3082	74	7	a	a	DET
ijpds-3082	74	8	,	,	PUNCT
ijpds-3082	74	9	valeyrie	valeyrie	NOUN
ijpds-3082	74	10	-	-	PUNCT
ijpds-3082	74	11	allanore	allanore	NOUN
ijpds-3082	74	12	l	l	NOUN
ijpds-3082	74	13	,	,	PUNCT
ijpds-3082	74	14	et	et	PROPN
ijpds-3082	74	15	al	al	PROPN
ijpds-3082	74	16	.	.	PROPN
ijpds-3082	75	1	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	75	2	1	1	NUM
ijpds-3082	75	3	french	french	ADJ
ijpds-3082	75	4	national	national	ADJ
ijpds-3082	75	5	guidelines	guideline	NOUN
ijpds-3082	75	6	based	base	VERB
ijpds-3082	75	7	on	on	ADP
ijpds-3082	75	8	an	an	DET
ijpds-3082	75	9	extensive	extensive	ADJ
ijpds-3082	75	10	literature	literature	NOUN
ijpds-3082	75	11	review	review	NOUN
ijpds-3082	75	12	since	since	SCONJ
ijpds-3082	75	13	1966	1966	NUM
ijpds-3082	75	14	.	.	PUNCT
ijpds-3082	76	1	orphanet	orphanet	PROPN
ijpds-3082	76	2	j	j	PROPN
ijpds-3082	76	3	rare	rare	ADJ
ijpds-3082	76	4	dis	dis	PROPN
ijpds-3082	76	5	.	.	PUNCT
ijpds-3082	77	1	2020	2020	NUM
ijpds-3082	77	2	;	;	PUNCT
ijpds-3082	77	3	15(1):37	15(1):37	NUM
ijpds-3082	77	4	.	.	PUNCT
ijpds-3082	78	1	5	5	NUM
ijpds-3082	78	2	.	.	X
ijpds-3082	78	3	ferner	ferner	PROPN
ijpds-3082	78	4	re	re	PROPN
ijpds-3082	78	5	,	,	PUNCT
ijpds-3082	78	6	huson	huson	PROPN
ijpds-3082	78	7	sm	sm	PROPN
ijpds-3082	78	8	,	,	PUNCT
ijpds-3082	78	9	thomas	thomas	PROPN
ijpds-3082	78	10	n	n	PROPN
ijpds-3082	78	11	,	,	PUNCT
ijpds-3082	78	12	et	et	PROPN
ijpds-3082	78	13	al	al	PROPN
ijpds-3082	78	14	.	.	PUNCT
ijpds-3082	79	1	guidelines	guideline	NOUN
ijpds-3082	79	2	for	for	ADP
ijpds-3082	79	3	the	the	DET
ijpds-3082	79	4	diagnosis	diagnosis	NOUN
ijpds-3082	79	5	and	and	CCONJ
ijpds-3082	79	6	management	management	NOUN
ijpds-3082	79	7	of	of	ADP
ijpds-3082	79	8	individuals	individual	NOUN
ijpds-3082	79	9	with	with	ADP
ijpds-3082	79	10	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	79	11	1	1	NUM
ijpds-3082	79	12	.	.	PUNCT
ijpds-3082	80	1	j	j	PROPN
ijpds-3082	80	2	med	med	PROPN
ijpds-3082	80	3	genet	genet	PROPN
ijpds-3082	80	4	.	.	PUNCT
ijpds-3082	81	1	2007	2007	NUM
ijpds-3082	81	2	;	;	PUNCT
ijpds-3082	81	3	44(2):81	44(2):81	NUM
ijpds-3082	81	4	-	-	SYM
ijpds-3082	81	5	88	88	NUM
ijpds-3082	81	6	.	.	PUNCT
ijpds-3082	82	1	6	6	NUM
ijpds-3082	82	2	.	.	PUNCT
ijpds-3082	82	3	karaconji	karaconji	PROPN
ijpds-3082	82	4	t	t	PROPN
ijpds-3082	82	5	,	,	PUNCT
ijpds-3082	82	6	whist	whist	NOUN
ijpds-3082	82	7	e	e	NOUN
ijpds-3082	82	8	,	,	PUNCT
ijpds-3082	82	9	jamieson	jamieson	PROPN
ijpds-3082	82	10	rv	rv	PROPN
ijpds-3082	82	11	,	,	PUNCT
ijpds-3082	82	12	et	et	PROPN
ijpds-3082	83	1	al	al	PROPN
ijpds-3082	83	2	.	.	PROPN
ijpds-3082	83	3	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	83	4	type	type	NOUN
ijpds-3082	83	5	1	1	NUM
ijpds-3082	83	6	:	:	PUNCT
ijpds-3082	83	7	review	review	NOUN
ijpds-3082	83	8	and	and	CCONJ
ijpds-3082	83	9	update	update	VERB
ijpds-3082	83	10	on	on	ADP
ijpds-3082	83	11	emerging	emerge	VERB
ijpds-3082	83	12	therapies	therapy	NOUN
ijpds-3082	83	13	.	.	PUNCT
ijpds-3082	84	1	asia	asia	PROPN
ijpds-3082	84	2	pac	pac	PROPN
ijpds-3082	84	3	jophthalmol	jophthalmol	PROPN
ijpds-3082	84	4	.	.	PROPN
ijpds-3082	84	5	2019	2019	NUM
ijpds-3082	84	6	;	;	PUNCT
ijpds-3082	84	7	8(1):62	8(1):62	NUM
ijpds-3082	84	8	-	-	SYM
ijpds-3082	84	9	72	72	NUM
ijpds-3082	84	10	.	.	PUNCT
ijpds-3082	85	1	7	7	X
ijpds-3082	85	2	.	.	X
ijpds-3082	85	3	ortonne	ortonne	NOUN
ijpds-3082	85	4	n	n	CCONJ
ijpds-3082	85	5	,	,	PUNCT
ijpds-3082	85	6	wolkenstein	wolkenstein	NOUN
ijpds-3082	85	7	p	p	NOUN
ijpds-3082	85	8	,	,	PUNCT
ijpds-3082	85	9	blakeley	blakeley	PROPN
ijpds-3082	85	10	jo	jo	PROPN
ijpds-3082	85	11	,	,	PUNCT
ijpds-3082	85	12	et	et	PROPN
ijpds-3082	85	13	al	al	PROPN
ijpds-3082	85	14	.	.	PUNCT
ijpds-3082	86	1	cutaneous	cutaneous	ADJ
ijpds-3082	86	2	neurofibromas	neurofibroma	NOUN
ijpds-3082	86	3	:	:	PUNCT
ijpds-3082	86	4	current	current	ADJ
ijpds-3082	86	5	clinical	clinical	ADJ
ijpds-3082	86	6	and	and	CCONJ
ijpds-3082	86	7	pathologic	pathologic	ADJ
ijpds-3082	86	8	issues	issue	NOUN
ijpds-3082	86	9	.	.	PUNCT
ijpds-3082	87	1	neurology	neurology	NOUN
ijpds-3082	87	2	.	.	PUNCT
ijpds-3082	88	1	2018	2018	NUM
ijpds-3082	88	2	;	;	PUNCT
ijpds-3082	88	3	91:5	91:5	NUM
ijpds-3082	88	4	-	-	SYM
ijpds-3082	88	5	13	13	NUM
ijpds-3082	88	6	.	.	NOUN
ijpds-3082	88	7	8	8	NUM
ijpds-3082	88	8	.	.	X
ijpds-3082	89	1	rallis	rallis	PROPN
ijpds-3082	89	2	e	e	PROPN
ijpds-3082	89	3	,	,	PUNCT
ijpds-3082	89	4	ragiadakou	ragiadakou	PROPN
ijpds-3082	89	5	d.	d.	PROPN
ijpds-3082	89	6	giant	giant	PROPN
ijpds-3082	89	7	plexiformneurofibroma	plexiformneurofibroma	NOUN
ijpds-3082	89	8	in	in	ADP
ijpds-3082	89	9	a	a	DET
ijpds-3082	89	10	patient	patient	NOUN
ijpds-3082	89	11	with	with	ADP
ijpds-3082	89	12	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	89	13	type	type	NOUN
ijpds-3082	89	14	i.	i.	NOUN
ijpds-3082	89	15	dermatol	dermatol	PROPN
ijpds-3082	89	16	online	online	PROPN
ijpds-3082	89	17	j.	j.	PROPN
ijpds-3082	89	18	2009	2009	NUM
ijpds-3082	89	19	;	;	PUNCT
ijpds-3082	89	20	15(5):7	15(5):7	NUM
ijpds-3082	89	21	.	.	PUNCT
ijpds-3082	90	1	9	9	X
ijpds-3082	90	2	.	.	X
ijpds-3082	90	3	fijałkowska	fijałkowska	PROPN
ijpds-3082	90	4	m	m	PROPN
ijpds-3082	90	5	,	,	PUNCT
ijpds-3082	90	6	antoszewski	antoszewski	PROPN
ijpds-3082	90	7	b.	b.	PROPN
ijpds-3082	90	8	clinical	clinical	ADJ
ijpds-3082	90	9	picture	picture	NOUN
ijpds-3082	90	10	and	and	CCONJ
ijpds-3082	90	11	treatment	treatment	NOUN
ijpds-3082	90	12	of	of	ADP
ijpds-3082	90	13	cutaneous	cutaneous	ADJ
ijpds-3082	90	14	lesions	lesion	NOUN
ijpds-3082	90	15	in	in	ADP
ijpds-3082	90	16	patients	patient	NOUN
ijpds-3082	90	17	with	with	ADP
ijpds-3082	90	18	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	90	19	type	type	NOUN
ijpds-3082	90	20	1	1	NUM
ijpds-3082	90	21	.	.	PUNCT
ijpds-3082	90	22	postepy	postepy	ADJ
ijpds-3082	90	23	dermatol	dermatol	NOUN
ijpds-3082	90	24	alergol	alergol	NOUN
ijpds-3082	90	25	.	.	PUNCT
ijpds-3082	91	1	2020	2020	NUM
ijpds-3082	91	2	;	;	PUNCT
ijpds-3082	91	3	37(5):781	37(5):781	NUM
ijpds-3082	91	4	-	-	SYM
ijpds-3082	91	5	784	784	NUM
ijpds-3082	91	6	.	.	PUNCT
ijpds-3082	92	1	10	10	NUM
ijpds-3082	92	2	.	.	PUNCT
ijpds-3082	93	1	ferner	ferner	PROPN
ijpds-3082	93	2	re	re	PROPN
ijpds-3082	93	3	,	,	PUNCT
ijpds-3082	93	4	gutmann	gutmann	PROPN
ijpds-3082	93	5	dh	dh	PROPN
ijpds-3082	93	6	.	.	PUNCT
ijpds-3082	94	1	international	international	ADJ
ijpds-3082	94	2	consensus	consensus	NOUN
ijpds-3082	94	3	statement	statement	NOUN
ijpds-3082	94	4	on	on	ADP
ijpds-3082	94	5	malignant	malignant	ADJ
ijpds-3082	94	6	peripheral	peripheral	ADJ
ijpds-3082	94	7	nerve	nerve	NOUN
ijpds-3082	94	8	sheath	sheath	NOUN
ijpds-3082	94	9	tumors	tumor	NOUN
ijpds-3082	94	10	in	in	ADP
ijpds-3082	94	11	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	94	12	.	.	PUNCT
ijpds-3082	95	1	cancer	cancer	NOUN
ijpds-3082	95	2	res	re	NOUN
ijpds-3082	95	3	.	.	PUNCT
ijpds-3082	95	4	2002	2002	NUM
ijpds-3082	95	5	;	;	PUNCT
ijpds-3082	95	6	62(5):1573	62(5):1573	NUM
ijpds-3082	95	7	-	-	SYM
ijpds-3082	95	8	1577	1577	NUM
ijpds-3082	95	9	.	.	PUNCT
ijpds-3082	96	1	how	how	SCONJ
ijpds-3082	96	2	to	to	PART
ijpds-3082	96	3	cite	cite	VERB
ijpds-3082	96	4	this	this	DET
ijpds-3082	96	5	article	article	NOUN
ijpds-3082	96	6	:	:	PUNCT
ijpds-3082	96	7	padmakar	padmakar	PROPN
ijpds-3082	96	8	s.	s.	PROPN
ijpds-3082	96	9	a	a	DET
ijpds-3082	96	10	case	case	NOUN
ijpds-3082	96	11	report	report	NOUN
ijpds-3082	96	12	on	on	ADP
ijpds-3082	96	13	neurofibromatosis	neurofibromatosis	NOUN
ijpds-3082	96	14	associated	associate	VERB
ijpds-3082	96	15	with	with	ADP
ijpds-3082	96	16	infective	infective	ADJ
ijpds-3082	96	17	mass	mass	NOUN
ijpds-3082	96	18	tumor	tumor	NOUN
ijpds-3082	96	19	.	.	PUNCT
ijpds-3082	97	1	indian	indian	PROPN
ijpds-3082	97	2	j	j	PROPN
ijpds-3082	97	3	pharm	pharm	PROPN
ijpds-3082	97	4	drug	drug	PROPN
ijpds-3082	97	5	studies	study	NOUN
ijpds-3082	97	6	.	.	PUNCT
ijpds-3082	98	1	2022	2022	NUM
ijpds-3082	98	2	;	;	PUNCT
ijpds-3082	98	3	1(2	1(2	NUM
ijpds-3082	98	4	)	)	PUNCT
ijpds-3082	98	5	69	69	NUM
ijpds-3082	98	6	-	-	SYM
ijpds-3082	98	7	70	70	NUM
ijpds-3082	98	8	.	.	PUNCT
ijpds-3082	99	1	funding	funding	NOUN
ijpds-3082	99	2	:	:	PUNCT
ijpds-3082	99	3	none	none	NOUN
ijpds-3082	99	4	conflict	conflict	NOUN
ijpds-3082	99	5	of	of	ADP
ijpds-3082	99	6	interest	interest	NOUN
ijpds-3082	99	7	:	:	PUNCT
ijpds-3082	99	8	none	none	NOUN
ijpds-3082	99	9	stated	state	VERB